The present study will explore the relationship between serum TK1 concentration before radiotherapy and clinical stage, pathological type and molecular typing of breast cancer patients with type 2 diabetes mellitus (T2DM), and evaluate the prognostic value of serum TK1 concentration before radiotherapy in breast cancer patients with T2DM. This evidence concerns the gene TK1 and breast cancer.